Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.
暂无分享,去创建一个
Daniel Westreich | Mhairi Maskew | Matthew P Fox | D. Westreich | M. Fox | M. Maskew | A. Brennan | Alana T Brennan | Lynne McNamara | A Patrick MacPhail | A. P. MacPhail | L. McNamara
[1] C. Wiysonge,et al. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review , 2007, BMC public health.
[2] C. Poole,et al. Gender Difference in HIV RNA Levels: A Meta‐Analysis of Published Studies , 2002, Journal of acquired immune deficiency syndromes.
[3] E. Graviss,et al. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Chaisson,et al. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy , 2001, AIDS.
[5] L. Myer,et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa , 2008, AIDS.
[6] A R Feinstein,et al. A new prognostic staging system for the acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.
[7] L. Ivers,et al. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] T. Flanigan,et al. Gender-based differences in treatment and outcome among HIV patients in South India. , 2008, Journal of women's health.
[9] Rachael Hughes,et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies , 2008, AIDS.
[10] J. Robins,et al. Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests , 2000, Biometrics.
[11] J. Goedert,et al. Serious infections during pregnancy among women with advanced human immunodeficiency virus infection. , 1990, American journal of obstetrics and gynecology.
[12] A. Phillips,et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. , 1996, Genitourinary medicine.
[13] M. Maskew,et al. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[14] Jayanta Bhattacharya,et al. The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes , 2009, Annals of Internal Medicine.
[15] M. Stein,et al. Human Immunodeficiency Virus Infection in North American Women: Experience with 200 Cases and a Review of the Literature , 1991, Medicine.
[16] Sally S Bebawy,et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. , 2009, The Journal of infectious diseases.
[17] A. Phillips,et al. Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study. , 2003, Journal of acquired immune deficiency syndromes.
[18] J. Sterne,et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.
[19] L. Myer,et al. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme , 2009, Tropical medicine & international health : TM & IH.
[20] E. Nicastri,et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy , 2005, AIDS.
[21] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[22] N. Low,et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. , 2008, Journal of women's health.
[23] Anne M Johnson,et al. Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited , 2003, Journal of acquired immune deficiency syndromes.
[24] N. Ford,et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa , 2010, AIDS.
[25] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[26] S. Makombe,et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi , 2006, AIDS.
[27] R. Barth,et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[28] R. Écochard,et al. Gender Differences in Immune Reconstitution: A Multicentric Cohort Analysis in Sub-Saharan Africa , 2012, PloS one.
[29] Kara Wools-Kaloustian,et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya , 2006, AIDS.
[30] J. Sterne,et al. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies , 2003, The Lancet.
[31] E. Bateman,et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. , 2008, Archives of internal medicine.
[32] Max Essex,et al. Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana , 2003, Journal of acquired immune deficiency syndromes.
[33] D. McCaffrey,et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.
[34] B. Yip,et al. Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based Cohort , 2004, Journal of acquired immune deficiency syndromes.
[35] J. Fleishman,et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons , 2007, Journal of General Internal Medicine.
[36] J. Moatti,et al. Impact of Early versus Late Adherence to Highly Active Antiretroviral Therapy on Immuno-Virological Response: A 3-Year Follow-Up Study , 2002, Antiviral therapy.
[37] Brian C. Zanoni,et al. Sex differences in HIV RNA level and CD4 cell percentage during childhood. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] Y. Lo,et al. Gender and Hospitalization Patterns Among HIV‐Infected Drug Users Before and After the Availability of Highly Active Antiretroviral Therapy , 2003, Journal of acquired immune deficiency syndromes.
[39] B. Boland,et al. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. , 1999, AIDS.
[40] W. Blattner,et al. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers , 1989, Journal of Clinical Immunology.
[41] E. Fish. The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.
[42] H. Sørensen,et al. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population , 2003, AIDS.
[43] T. Flanigan,et al. Lessons learned from use of highly active antiretroviral therapy in Africa. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] W. Cunningham,et al. The inability to take medications openly at home: does it help explain gender disparities in HAART use? , 2006, Journal of women's health.
[45] I. Sanne,et al. Using vital registration data to update mortality among patients lost to follow‐up from ART programmes: evidence from the Themba Lethu Clinic, South Africa , 2010, Tropical medicine & international health : TM & IH.